Columbus Circle Investors’s Haemonetics HAE Stock Holding History

Columbus Circle Investors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-80,990	Closed	-$8.07M	–	164
2020 Q1	$8.07M	Sell	80,990 -38,132	-32%	-$4.13M	0.44%	82
2019 Q4	$13.7M	Buy	119,122 +25,898	+28%	+$3.13M	0.59%	62
2019 Q3	$11.8M	Buy	93,224 +17,990	+24%	+$2.28M	0.43%	87
2019 Q2	$9.05M	Buy	+75,234	New	+$7.4M	0.24%	107
2019 Q1	–	Sell	-247,320	Closed	-$24.7M	–	161
2018 Q4	$24.7M	Sell	247,320 -54,432	-18%	-$5.72M	0.7%	61
2018 Q3	$34.6M	Buy	301,752 +41,074	+16%	+$4.25M	0.69%	52
2018 Q2	$23.4M	Buy	260,678 +61,375	+31%	+$5.18M	0.48%	87
2018 Q1	$14.6M	Buy	+199,303	New	+$13.7M	0.3%	111

Other funds holding HAE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Columbus Circle Investors's HAE Position: Q2 2020 in Review

Columbus Circle Investors sold out of Haemonetics (HAE) in Q2 2020, closing a stake of 80,990 shares — an estimated $8.07M sold.

Columbus Circle Investors first reported a position in HAE in Q1 2018 and held it in 8 quarters. The position peaked at $34.6M in Q3 2018. 285 funds tracked by Wall St. Rank hold HAE as of Q2 2020.

Columbus Circle Investors reported no remaining Haemonetics position as of Q2 2020 after selling out during the quarter.
Columbus Circle Investors sold 80,990 Haemonetics shares in Q2 2020, an estimated $8.07M.
Columbus Circle Investors first reported a position in Haemonetics in Q1 2018 and held it in 8 quarters.
Columbus Circle Investors's Haemonetics position peaked at $34.6M in Q3 2018.
285 funds tracked by Wall St. Rank held Haemonetics as of Q2 2020.

Based on Columbus Circle Investors's 13F filing for Q2 2020, filed 27 Jul 2020.